Quick Overview: Natalie Vokes, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the challenges of choosing ... Marc S. Ernstoff, MD from Roswell Park Cancer Institute, Buffalo, NY, talks about the challenges associated with immunotherapy ... Michail Ignatiadis, MD, PhD, Institut Jules Bordet, Brussels, Belgium, discusses novel
Optimizing Checkpoint Inhibitor Combinations In - Detailed Overview & Context
Natalie Vokes, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the challenges of choosing ... Marc S. Ernstoff, MD from Roswell Park Cancer Institute, Buffalo, NY, talks about the challenges associated with immunotherapy ... Michail Ignatiadis, MD, PhD, Institut Jules Bordet, Brussels, Belgium, discusses novel Thomas Powles, MD, MBBS, MRCP, director, Barts Cancer Institute, discusses how researchers are working to Sun Young Rha, MD, PhD, Yonsei Cancer Center, Seoul, South Korea, emphasizes the significance of immunotherapy and ... Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines observations from ...
Yale Cancer Center Grand Rounds May 21, 2019 Roy Decker, MD, PhD, Vice Chair for Clinical Research and Professor of ... Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Cancer Center, Houston, TX, talks on overcoming PARP ... In this interview, Christopher Campen, PharmD, BCOP, from the GHS Cancer Institute, Greenville, SC, discusses combining ... Joyce A. O'Shaughnessy, MD; Komal Jhaveri, MD, FACP; Hope S. Rugo, MD; and Debu Tripathy, MD, discuss the potential role ... Mark Robson, MD, of Memorial Sloan Kettering Cancer Center, explores the evolving role of PARP Keith Flaherty, MD; Jason Luke, MD, FACP; Rene Gonzalez, MD; and Jeffrey Weber, MD, PhD, examine the risks and benefits ...
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Stephen M. Ansell, MD, PhD, of Mayo Clinic, ... In this segment, panelists discuss the exploration of immune This video is part of a larger CE/CME Certified program entitled: Navigating First-Line In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vassiliki Papadimitrakopoulou argues in favor of ... Matthew Ulrickson, MD, Banner MD Anderson Cancer Center, Gilbert, AZ, briefly discusses potential
